skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Insulin, NPH (Code C29124)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Insulin, NPH

Definition: An intermediate-acting insulin used in the treatment of diabetes mellitus. Administered once or twice daily, NPH (neutral protamine hagedorn) insulin lowers blood glucose within 1 to 2 hours after administration and exerts a peak effect at 6 to 10 hours. Endogenous insulin, a pancreatic hormone composed of two polypeptide chains, is important in the normal metabolism of carbohydrates, proteins and fats, promoting glucose utilization and protein synthesis; it has anabolic effects on many types of tissues. (NCI04)

Display Name: Insulin, NPH

Label: Insulin, NPH

NCI Thesaurus Code: C29124 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0021658  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Humulin N
Insulin, NPH
Novolin N

External Source Codes: 
PDQ Closed Trial Search ID 752151
PDQ Open Trial Search ID 752151 (check for NCI PDQ open clinical trial info)
UMLS CUI C0021658

Other Properties:
     Name Value (qualifiers indented underneath)
code C29124
Contributing_Source CTRP
Legacy_Concept_Name NPH_Insulin
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom